Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder
Clinical trial NCT04745026 · COMPLETED
Trial details
- NCT number
- NCT04745026
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-31
- Primary completion
- 2023-12-21
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.